Skip to main content

Research Repository

Advanced Search

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair

Johnston, Simon J.; Ahmad, Dena; Aleskandarany, Mohammed A.; Kurozumi, Sasagu; Nolan, Chris C.; Diez-Rodriguez, Maria; Green, Andrew R.; Rakha, Emad A.

Authors

Simon J. Johnston

Dena Ahmad

Mohammed A. Aleskandarany

Sasagu Kurozumi

Chris C. Nolan

Maria Diez-Rodriguez

EMAD RAKHA Emad.Rakha@nottingham.ac.uk
Professor of Breast Cancer Pathology



Journal Article Type Article
Publication Date Oct 23, 2018
Journal BMC Cancer
Electronic ISSN 1471-2407
Publisher BMC
Peer Reviewed Peer Reviewed
Volume 18
Article Number 1027
APA6 Citation Johnston, S. J., Ahmad, D., Aleskandarany, M. A., Kurozumi, S., Nolan, C. C., Diez-Rodriguez, M., …Rakha, E. A. (2018). Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair. BMC Cancer, 18, doi:10.1186/s12885-018-4924-2
DOI https://doi.org/10.1186/s12885-018-4924-2
Keywords Breast cancer; P38; MAPK; Oestrogen receptor; Adjuvant; Survival; Prognosis
Publisher URL https://bmccancer.biomedcentral.com/articles/10.1186/s12885-018-4924-2

Files







You might also like



Downloadable Citations

;